Lateral Flow Assay Quantifying SARS-Cov-2 Neutralizing Antibody Titer
Invention type: Technology
/
Case number: #23869
Researchers
Hojun Li
/ Guinevere Connelly
Departments: David H Koch Institute for Integrative Cancer Res
Technology Areas: Biotechnology: Biomedical Devices & Systems / Diagnostics: Assays
Impact Areas: Healthy Living
-
direct capture of neutralized rbd enables rapid point-of-care assessment of sars-cov-2 neutralizing antibody titer
Patent Cooperation Treaty | Published application
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.